# AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

> **NCT04006405** · — · COMPLETED · sponsor: **Elypta** · enrollment: 280 (actual)

## Conditions studied

- Clear Cell Renal Cell Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** GAG score

## Key facts

- **NCT ID:** NCT04006405
- **Lead sponsor:** Elypta
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-10
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-05-07
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04006405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04006405, "AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04006405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*